Search results
Stephens Inc. AR Has $1.78 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 5 days agoStephens Inc. AR increased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 18.3% in the 4th quarter, according to its most recent disclosure with the ...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 1 day agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 13 hours agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 4 days agoNovo Nordisk stock also earns a spot on the IBD 50 list of top growth stocks, as well as IBD...
AstraZeneca (LON:AZN) Given New £150 Price Target at Berenberg Bank
ETF DAILY NEWS· 5 days agoAstraZeneca (LON:AZN – Get Free Report) had its target price increased by equities research analysts at Berenberg Bank from £130 ($166.56) to £150 ($192.18) in a research ...
Lighthouse Investment Partners LLC Takes $421,000 Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 3 days agoLighthouse Investment Partners LLC bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought ...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 5 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, ...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 4 days agoInvestors should also take note of any recent adjustments to analyst estimates for Astrazeneca....
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 1 day agoThe company had two earlier flops in COPD treatment, but is now running a Phase 3 study of more than...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...